April 3 (Reuters) - Avecho Biotechnology Ltd (AVE) :
- UNDERTAKING A CAPITAL RAISE SEEKING APPROXIMATELY A$11 MILLION
- RAISE TO FUND PIVOTAL PHASE 3 CLINICAL TRIAL DESIGNED TO TEST CO'S PROPRIETARY CBD SOFT-GEL CAPSULE
- CAPITAL RAISING AT AN ISSUE PRICE OF A$0.006 PER SHARE
- Forums
- ASX - By Stock
- News: AVE Avecho Biotechnology Says Undertaking A Capital Raise
April 3 (Reuters) - Avecho Biotechnology Ltd (AVE) :...
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.036K | 678.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39213243 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.002 |
32 | 75717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39213222 | 29 |
0.004 | 30014232 | 16 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 14.26pm 13/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online